GYRE
Gyre Therapeutics Inc

9,479
Mkt Cap
$684.83M
Volume
11,691.00
52W High
$19.00
52W Low
$6.11
PE Ratio
462.58
GYRE Fundamentals
Price
$7.56
Prev Close
$7.54
Open
$7.61
50D MA
$7.80
Beta
1.29
Avg. Volume
102,839.86
EPS (Annual)
$0.0481
P/B
7.44
Rev/Employee
$21.15M
Loading...
Loading...
Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). The firm operates through the BC and Gyre segments. The company was founded on March 7, 1997 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
5

Frequently Asked Questions

What is Market Cap of Gyre Therapeutics Inc?
What is the 52-week high for Gyre Therapeutics Inc?
What is the 52-week low for Gyre Therapeutics Inc?
What is Gyre Therapeutics Inc stock price today?
What was Gyre Therapeutics Inc stock price yesterday?
What is the PE ratio of Gyre Therapeutics Inc?
What is the Price-to-Book ratio of Gyre Therapeutics Inc?
What is the 50-day moving average of Gyre Therapeutics Inc?
How many employess does Gyre Therapeutics Inc has?

Latest GYRE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.